Direct evidence of the adverse effects of insulin on lung function was supported by a greater than 15% decrease in FEV1 in 1.3% of patients with type 1 diabetes and 5% of patients with type 2 diabetes mellitus following administration of inhaled insulin as therapy for diabetes [23]. Here, INS is linked to type 1 diabetes mellitus.